Clinical trial
A Study of 18F-FLT Positron Emission Tomography (PET)/Computed Tomography Imaging in Pediatrics With Myeloproliferative Neoplasms
NCT03121599 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of 18F-FLT Positron Emission Tomography (PET)/Computed Tomography Imaging in Pediatrics With Myeloproliferative Neoplasms
- Lead sponsor
- Hamad Medical Corporation
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 11, 2017
- Completion date
- October 16, 2018
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
essential thrombocythemia, polycythemia vera, primary myelofibrosis, fibrotic stage, primary myelofibrosis, prefibrotic stage